The
nociceptin/orphanin FQ (
N/OFQ) peptide (NOP) receptor is a novel member of the
opioid receptor family with little affinity for traditional
opioids. This receptor and its endogenous
ligand, N/OFQ, are widely distributed in the brain and are implicated in many physiological functions including
pain regulation. [(pF)Phe(4),Arg(14),Lys(15)]N/OFQ-NH(2) (UFP-102) is a newly developed
peptide agonist of NOP receptors. In this study, we quantitatively investigated the effect of
UFP-102 at native NOP receptors of the ventrolateral periaqueductal gray (PAG), a crucial midbrain area involved in
pain regulation and enriched with NOP receptors, using blind patch-clamp whole-cell recording technique in rat brain slices.
UFP-102, like N/OFQ, induced an outward current in ventrolateral PAG neurons and increased the membrane current elicited by a hyperpolarization ramp from -60 to -140 mV. The current induced by
UFP-102 was characterized with inward rectification and had a reversal potential near the equilibrium potential of K(+)
ions, indicating that
UFP-102 activates
G-protein coupled inwardly rectifying K(+) channels. The effect of
UFP-102 was concentration-dependent with the maximal effect similar to that of N/OFQ. The EC(50) value was 11+/-2 nM, which is 5 fold lower than that of N/OFQ. The effect of
UFP-102 was not affected by
naloxone while competitively antagonized by
UFP-101 ([Nphe(1),Arg(14),Lys(15)]N/OFQ-NH(2)), a potent NOP receptor antagonist, with a pA(2) value of 6.7. These results suggest that
UFP-102 is a full agonist at the postsynaptic NOP receptors of the midbrain of rats and is 5 fold more potent than N/OFQ.